Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma.

Ansari, J., Hussain, S.A. orcid.org/0000-0003-1552-511X, Ansari, A. et al. (1 more author) (2013) Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma. Biologics: Targets and Therapy, 7. pp. 39-46. ISSN 1177-5475

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2013 Ansari et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. https://creativecommons.org/licenses/by-nc/3.0/
Keywords: metastatic RCC; vascular endothelial growth factor receptor inhibitor; molecular targeted agent; clear-cell carcinoma
Dates:
  • Accepted: 22 November 2013
  • Published: 28 February 2013
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 02 May 2019 11:10
Last Modified: 02 May 2019 11:13
Status: Published
Publisher: Dove Medical Press
Refereed: Yes
Identification Number: https://doi.org/10.2147/BTT.S25862
Related URLs:

Share / Export

Statistics